Get the Stockscreener App
77.13
0.52%
0.52
Henry Schein Inc stock is traded at $77.13, with a volume of 667.05K.
It is up +0.52% in the last 24 hours and up +8.15% over the past month.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
See More
Previous Close:
$76.61
Open:
$76.6
24h Volume:
667.05K
Relative Volume:
0.45
Market Cap:
$9.07B
Revenue:
$12.50B
Net Income/Loss:
$314.00M
P/E Ratio:
31.61
EPS:
2.44
Net Cash Flow:
$421.00M
1W Performance:
+1.00%
1M Performance:
+8.15%
6M Performance:
+8.26%
1Y Performance:
+9.06%
1-Day Range:
$76.27
$77.14
1-Week Range:
$75.54
$77.74
52-Week Range:
$60.56
$82.49
Henry Schein Inc Stock (HSIC) Company Profile
Name
Henry Schein Inc
Sector
Industry
Phone
(631) 843-5500
Address
135 DURYEA RD, MELVILLE, NY
Compare HSIC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
77.03 | 9.02B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
811.03 | 99.55B | 387.09B | 4.23B | 6.01B | 32.12 |
|
COR
Cencora Inc
|
339.86 | 66.53B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
CAH
Cardinal Health Inc
|
199.09 | 47.15B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
AHG
Akso Health Group Adr
|
1.23 | 670.03M | 2.22M | -5.63M | -1.68M | -0.24 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Aug-26-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-25-25 | Downgrade | Stifel | Buy → Hold |
| Jul-14-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-14-25 | Initiated | Wells Fargo | Equal Weight |
| Jan-06-25 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Jul-22-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-12-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-10-23 | Upgrade | Stifel | Hold → Buy |
| Aug-08-22 | Upgrade | UBS | Sell → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| Jan-31-22 | Initiated | Morgan Stanley | Underweight |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Oct-01-21 | Resumed | Credit Suisse | Neutral |
| Feb-08-21 | Resumed | Piper Sandler | Overweight |
| Jan-04-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-03-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Apr-07-20 | Upgrade | Goldman | Neutral → Buy |
| Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-09-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-02-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| May-15-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Jan-17-19 | Initiated | UBS | Sell |
| Jan-03-19 | Downgrade | Evercore ISI | In-line → Underperform |
| Jan-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-08-18 | Reiterated | Barrington Research | Outperform |
| Oct-25-18 | Downgrade | Edward Jones | Hold → Sell |
| Oct-19-18 | Resumed | Goldman | Neutral |
| Oct-04-18 | Reiterated | Robert W. Baird | Outperform |
| Aug-07-18 | Reiterated | Stifel | Hold |
| Apr-24-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-04-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
View All
Henry Schein Inc Stock (HSIC) Latest News
Highlights and insights from Henry Schein’s new report predicting 2026 dental data - Dental Economics
How Is Henry Schein's Stock Performance Compared to Other Healthcare Stocks? - inkl
DentScribe Joins Henry Schein One API Exchange as an Authorized Integration Vendor - StreetInsider
Squarepoint Ops LLC Boosts Holdings in Henry Schein, Inc. $HSIC - MarketBeat
Top 2 Health Care Stocks That May Keep You Up At Night In December - Benzinga
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Henry Schein, Inc.'s (NASDAQ:HSIC) Shareholders Might Be Looking For Exit - 富途牛牛
Westwood Holdings Group Inc. Invests $20.63 Million in Henry Schein, Inc. $HSIC - MarketBeat
Is Henry Schein Inc a good long term investmentHealthcare Stock Analysis & High Return Trading Strategies - earlytimes.in
Robert I. Schattner Oral Health Center for People with Disabilities established at Hebrew University-Hadassah School of Dental Medicine - EurekAlert!
Thompson Davis & CO. Inc. Buys Shares of 17,270 Henry Schein, Inc. $HSIC - MarketBeat
Loss Report: Will Henry Schein Inc stock benefit from infrastructure spendingOptions Play & Real-Time Sentiment Analysis - moha.gov.vn
Revenue per share of Henry Schein, Inc. – FWB:HS2 - TradingView — Track All Markets
Jim Cramer on Henry Schein: “I Think It’s a Good Stock” - MSN
Do Wall Street Analysts Like Henry Schein Stock? - MSN
Ilex Capital Partners UK LLP Takes Position in Henry Schein, Inc. $HSIC - MarketBeat
Did Henry Schein’s (HSIC) Expanded vVARDIS Deal Quietly Recast Its Minimally Invasive Dental Strategy? - simplywall.st
Henry Schein Expands Partnership with vVARDIS - Zenopa
California Public Employees Retirement System Sells 120,408 Shares of Henry Schein, Inc. $HSIC - MarketBeat
Amundi Has $14.03 Million Stock Holdings in Henry Schein, Inc. $HSIC - MarketBeat
Barclays Begins Coverage on Henry Schein (NASDAQ:HSIC) - MarketBeat
Is Henry Schein’s Streamlined Distribution Strategy Creating Value at Around $74 a Share in 2025? - simplywall.st
How Henry Schein’s (HSIC) Expanded Curodont Deal Could Reshape Its Technology-Enabled Margin Story - Yahoo Finance
Why Henry Schein (HSIC) Stock Is Up Today - The Globe and Mail
Henry Schein (HSIC) Announces Extension of Strategic Partnership Agreement - GuruFocus
Henry Schein, Inc. (HSIC): A Bull Case Theory - Finviz
Henry Schein One and AWS leverage generative AI to revolutionize dentistry - Amazon Web Services (AWS)
Henry Schein extends strategic partnership with KKR - MSN
SVB Wealth LLC Invests $1.42 Million in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein to renominate KKR designees to board for 2026 term By Investing.com - Investing.com Nigeria
Henry Schein to renominate KKR designees to board for 2026 term - Investing.com
Henry Schein Extends Strategic Partnership with KKR - TipRanks
Barclays Initiates Henry Schein With Overweight Rating, $86 Price Target - marketscreener.com
Henry Schein, Inc. $HSIC Shares Bought by Marshall Wace LLP - MarketBeat
Henry Schein Inc. stock outperforms competitors despite losses on the day - MarketWatch
Gabelli Funds LLC Sells 16,750 Shares of Henry Schein, Inc. $HSIC - MarketBeat
Resistance Check: Why Henry Schein Inc. stock remains undervaluedDollar Strength & Risk Controlled Daily Plans - BỘ NỘI VỤ
Arrowstreet Capital Limited Partnership Has $21.12 Million Holdings in Henry Schein, Inc. $HSIC - MarketBeat
409,100 Shares in Henry Schein, Inc. $HSIC Acquired by Oribel Capital Management LP - MarketBeat
Burgundy Asset Management Ltd. Sells 27,936 Shares of Henry Schein, Inc. $HSIC - MarketBeat
HSIC Stock Benefits From Expanded Partnership With vVARDIS - MSN
Stenger Family Office LLC Purchases New Stake in Henry Schein, Inc. $HSIC - MarketBeat
Invesco Ltd. Cuts Stake in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein Can Make Your Portfolio Smile (NASDAQ:HSIC) - Seeking Alpha
Henry Schein (HSIC): Revisiting Valuation After Expanded vVARDIS Distribution Deal in Preventive Dentistry - Sahm
Custom Nightguards Initiated in Dentrix Now Available from Henry Schein - Dentistry Today
Norges Bank Invests $89.48 Million in Henry Schein, Inc. $HSIC - MarketBeat
2025 Healthy Outcomes Conference: Henry Schein Canada reducing disability leave claims with wellness program - Benefits Canada.com
Why Is Henry Schein (HSIC) Up 1.2% Since Last Earnings Report? - Yahoo Finance
Hsbc Holdings PLC Raises Stake in Henry Schein, Inc. $HSIC - MarketBeat
How Investors May Respond To Henry Schein (HSIC) Gaining Exclusive U.S. Rights To Drill-Free Cavity Treatment - simplywall.st
Henry Schein Inc Stock (HSIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):